A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This study proposes to examine the effect of atomoxetine on quality of life and negative
symptoms such as social withdrawal, lack of interest in things, lack of thought content, flat
emotions, slowed body movements and lack of drive and motivation in patients with
schizophrenia or schizoaffective disorder. This study also examines the safety of using
atomoxetine along with the conventional antipsychotic in these patients.